Højgård Hestehospital Group A/S

Beskrivelse af virksomhedens væsentligste aktiviteter

Primary activitiesHøjgaard Hestehospital Group A/S is part of Altano Group, and the primary activities consist of the operation of equine clinics. Højgaard Hestehospital Group A/S is the largest Equine Practice in Denmark within Altano with the purpose of running veterinary and hospital activities as well as related activities. Højgaard Hestehospital Group A/S is located in the middle of Denmark on the island of Funen. In addition, the company has equine clinics in Aarhus, Aalborg and Zealand. Højgaard Hestehospital Group A/S offers a holistic veterinary service covering areas​such as orthopaedics, internal medicine, dentistry, ophthalmology, urogynecology and routine treatments.

Beskrivelse af usædvanlige forhold, der kan have påvirket indregningen eller målingen

Unusual circumstances affecting recognition and measurementThere have been no unusual circumstances affecting recognition and measurement.

Beskrivelse af udviklingen i virksomhedens aktiviteter og økonomiske forhold

Development in activities and financesAt the end of 2024, Højgaard Group A/S took over all horse clients from Vestfyn Dyrlægerne I/S, which has led to increased operational synergies and a more efficient use of resources.
However, the closure of our clinic on Mors has had a negative impact on turnover. In addition, the company has had several unbudgeted expenses for advice and consultancy, which has put a further strain on the economy.

Omtale af betydningsfulde hændelser, som er indtruffet efter regnskabsårets afslutning

Events after the balance sheet dateNo events have occurred after the balance sheet date to this date, which would influence the evaluation of this annual report.

Beskrivelse af virksomhedens forventede udvikling

OutlookHøjgaard Hestehospital Group A/S expects a positive development in 2025 with growth driven by both new and returning patients. In addition, we will strengthen cooperation with other clinics in the Altano Group to ensure the best treatment options for our customers.
​
​Several strategic initiatives have already been launched and are expected to contribute positively to the result. We expect an increase in net sales during 2025 and that the net profit will improve from a loss of DKK 1,6 million in 2024 to a positive result of approximately around DKK 1.0 million. Furthermore it is expected to improve the profit before depreciation and tax from DKK 5,5 million to DKK 9.0 million in 2025.